Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
Associated filings
- 28 Jun 24 424B2 Prospectus for primary offering
- 28 Jun 24 FWP Free writing prospectus
- 27 Jun 24 424B5 Prospectus supplement for primary offering
-
26 Jun 24 F-3ASR Automatic shelf registration (foreign)
TAK similar filings
Filing view
External links
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
We consent to the use of our reports dated June 26, 2024, with respect to the consolidated financial statements of Takeda Pharmaceutical Company Limited, and the effectiveness of internal control over financial reporting, incorporated herein by reference and to the reference to our firm under the heading “Experts” in the prospectus.
/s/KPMG AZSA LLC
Tokyo, Japan
June 26, 2024